When a new drug is approved and enters the marketplace, often the only safety and efficacy information available is based on a few thousand people who took the drug during strictly controlled clinical trials. Not surprisingly, these trials are designed to focus on the drugs’ benefits, and may not include a large enough sample size to elicit serious adverse effects. Once the drug is available for widespread use, we are able to better evaluate the real safety profile of the drug. Read more →

Alcohol use by underage college students has increasingly grown as a large issue across the United States. Excessive, or binge drinking among college students is associated with a variety of negative consequences, such as a decrease in academic productivity, unwanted sexual encounters and an increase in violent behavior.

Many colleges have made an attempt to examine the root cause of such extreme drinking by students, and have developed programs to deter students from consuming alcohol. Read more →

In October, the Federal Drug Administration approved lacosamide as add-on therapy for adults with partial seizures. The approval is based on data from multiple phase 1, 2, and 3 clinical trials involving approximately 1300 people.

The study participants were aged 16 years or older, and experienced between 10 and 17 seizures per month. Patients continued to take 1 to 3 previously prescribed antiepileptic drugs (AEDs) while taking lacosamide in the study. Nearly half of the study participants had tried 7 or more AEDs, and still experienced a lack of seizure control. Read more →

Most Americans are willing to pay higher taxes to make health care reform possible, but, like politicians, they disagree about what reforms should take place.

Should the government mandate a health care plan or should insurance carriers do a better job of providing coverage?

The Democrats, led by Presidential candidate Senator Barack Obama, plan to rely on a “play or pay” system that would improve access to insurance and move the United States toward universal coverage. Read more →

No matter which side of the political fence you sit on, most Americans agree that our health care system is broken. Health care costs in the United States are approximately 16% of our gross domestic product (GDP), and they are expected to reach 20% of the GDP by 2017. That amounts to a staggering $4.3 trillion! Costs are clearly out of control, yet 47 million Americans remain uninsured.

Health care reform is an important issue of the 2008 Presidential election, and both Republicans and Democrats are proposing radical changes that will change the face of health care delivery in this country. Read more →

Nobody questions the fact that healthcare is a confusing profession. Doctors and nurses seem to speak in foreign tongues; medicines have names and ingredients that are not even pronounceable; more and more news comes out every day about diseases and conditions that seem to contradict each other. If doctors must devote 12 years of higher education just to get a basic understanding of how the body works, how does a patient hope to know what’s wrong with them? Read more →